A meta-analysis evaluating a large sample of patients (n = 28,319) found a significant positive association between circulating PCSK9 concentration and the risk of major adverse cardiovascular events [38], suggesting that inhibition of PCSK9 expression reduces serum LDL levels and the risk of cardiovascular disease [5,39]. This evidence concerns the gene PCSK9 and cardiovascular disorder.